10 electrolyte Imbalance questions from the ICU Basics bank. Tap an answer to see whether you were right, with a rationale for every choice. Your score is at the end.
A patient with HFrEF and hypervolemic hyponatremia received a first dose of tolvaptan 15 mg at 0800 and was told to drink to thirst. The patient is alert, with mild fatigue. Data are:
0800 Na⁺ 119 mEq/L
1600 Na⁺ 126 mEq/L
2400 Na⁺ 132 mEq/L
Urine output 300 to 400 mL/h since 1000
Which action is MOST appropriate now?
Replace hourly urine output with an equal volume of 0.9% saline
Start a 1,000 mL daily fluid restriction to hold the sodium near normal
Ask the provider to stop tolvaptan and consider hypotonic fluid
Recheck the sodium with the morning laboratory draw, as it is close to normal
Show the answer and rationale
Answer: C
A. Matching losses seems to protect volume status, but isotonic saline does not lower the sodium, adds sodium and water to a congested patient, and does not slow the correction.
B. Fluid restriction suits hyponatremia in heart failure in general, but during the first 24 hours of tolvaptan it raises the risk of overly rapid correction.
C.Correct. Sodium has risen 13 mEq/L in 16 hours, past the 12 mEq/L in 24 hours that the label links to osmotic demyelination, so treatment is interrupted and hypotonic fluid is considered.
D. A value of 132 mEq/L looks reassuring, but the danger is the rate of rise, not the number. Waiting 6 to 8 hours while the aquaresis continues invites further overcorrection.
Tolvaptan, a vasopressin V2 antagonist, causes free-water loss (aquaresis). Its boxed warning requires starting it in a hospital where sodium can be monitored closely, because correction faster than about 12 mEq/L in 24 hours can cause osmotic demyelination, with dysarthria, dysphagia, quadriparesis or seizures appearing days later. Here sodium rose from 119 to 132 mEq/L in 16 hours. The label says to discontinue or interrupt the drug and consider hypotonic fluid. Fluid restriction is avoided in the first 24 hours because it speeds correction. Tolvaptan is not used for longer than 30 days, because of liver injury, and is contraindicated in hypovolemic hyponatremia.
A patient with small-cell lung cancer has a sodium of 118 mEq/L, serum osmolality 250 mOsm/kg, urine osmolality 600 mOsm/kg, and is euvolemic. Which initial intervention is MOST appropriate?
Rapid infusion of normal saline at 250 mL/hr
Desmopressin to reduce urine output
Fluid restriction to 800 to 1,000 mL per day
Encourage oral fluids to dilute the urine
Show the answer and rationale
Answer: C
A. In SIADH the kidney excretes the sodium and retains the water from isotonic saline, which can lower sodium further.
B. Desmopressin is ADH; it would worsen water retention.
C.Correct. SIADH with mild to moderate symptoms is first treated with fluid restriction; the concentrated urine confirms inappropriate ADH.
D. More free water directly worsens the hyponatremia.
SIADH causes euvolemic hyponatremia with inappropriately concentrated urine. Treatment is fluid restriction, treating the cause, and salt tablets or a vasopressin antagonist if needed. Hypertonic saline is reserved for seizures or severe symptoms, with correction limited to 8 mEq/L in 24 hours to prevent osmotic demyelination.
A patient with CKD who has missed two dialysis sessions presents with dyspnea, perioral tingling, and carpopedal spasm when the BP cuff inflates. Labs show phosphate 9.8 mg/dL and ionized calcium 0.84 mmol/L. In addition to treating the volume overload, which medication should the nurse anticipate?
IV magnesium sulfate
IV calcium gluconate
An oral phosphate binder as the only acute therapy
IV potassium chloride
Show the answer and rationale
Answer: B
A. Patients with CKD often have high magnesium, and magnesium does not treat this hypocalcemia.
B.Correct. Symptomatic hypocalcemia (tetany, Trousseau sign) requires IV calcium, followed by dialysis to lower phosphate.
C. Binders help chronically, but symptomatic hypocalcemia needs IV calcium now.
D. Patients who miss dialysis are typically hyperkalemic, so potassium is contraindicated.
In CKD, reduced phosphate excretion causes hyperphosphatemia, which binds calcium and, together with reduced activation of vitamin D, causes hypocalcemia and secondary hyperparathyroidism. Symptomatic hypocalcemia (paresthesias, tetany, Chvostek and Trousseau signs, prolonged QT, seizures) is treated with IV calcium gluconate. Dialysis corrects phosphate, potassium, and volume. Very high calcium–phosphate products carry a risk of metastatic calcification, so IV calcium is given at the minimum needed for symptoms.
A 28-year-old man who stopped taking prescribed propranolol presents with sudden weakness of all four limbs after a high-carbohydrate meal. Data: HR 112, BP 128/70 mm Hg, TSH 0.005 mIU/L (low), free T4 elevated, and K⁺ 2.2 mEq/L. The ECG shows U waves. Which treatment consideration is MOST important?
Give IV calcium gluconate for membrane stabilization
Give insulin with dextrose to stabilize the K⁺
Give propranolol and replace K⁺ cautiously with frequent checks
Give aggressive potassium replacement at 40 mEq/hr until normal
Show the answer and rationale
Answer: C
A. Calcium is for hyperkalemia with ECG changes, not hypokalemic paralysis.
B. Insulin drives potassium into cells and worsens hypokalemia.
C.Correct. Nonselective β-blockade reverses the potassium shift, and modest potassium replacement avoids rebound hyperkalemia.
D. Potassium shifts back out of cells as the paralysis resolves. Aggressive replacement risks rebound hyperkalemia.
Thyrotoxic periodic paralysis, which is more common in young men of Asian descent, causes acute weakness from a sudden intracellular potassium shift driven by thyroid hormone and adrenergic activity increasing Na⁺/K⁺-ATPase. Triggers include carbohydrate loads, exercise, and stress. Total body potassium is normal, so a nonselective β-blocker (propranolol) and small, monitored potassium doses are given, with rebound hyperkalemia watched for. The ECG shows hypokalemic changes (U waves, prolonged QT). Definitive treatment is controlling the hyperthyroidism.
A 66-year-old patient is admitted to the ICU with confusion and Na⁺ 119 mEq/L. Data are: serum osmolality 248 mOsm/kg, urine osmolality 480 mOsm/kg, urine Na⁺ 64 mEq/L, BP 132/80 mm Hg, moist mucous membranes, no edema. Thyroid and cortisol levels are normal. Which medication started 3 weeks ago is MOST likely contributing?
Demeclocycline for inflammatory acne
Furosemide for dependent ankle edema
Carbamazepine for trigeminal neuralgia
Lithium carbonate for bipolar I disorder
Show the answer and rationale
Answer: C
A. Demeclocycline is linked to SIADH because it is used to treat it: it blunts the kidney response to vasopressin, which would raise rather than lower the sodium.
B. Diuretics come to mind with hyponatremia, but loop diuretics cause it much less often than thiazides, and this patient shows no sign of volume depletion.
C.Correct. Carbamazepine stimulates vasopressin release and is a recognized drug cause of SIADH, which fits euvolemic hyponatremia with inappropriately concentrated urine.
D. Tempting because lithium is the classic water-balance drug, but it makes the kidney resistant to vasopressin (nephrogenic diabetes insipidus), which produces dilute urine and a tendency toward a high sodium.
Hypotonic hyponatremia with concentrated urine (osmolality well above 100 mOsm/kg), a urine sodium that is not low, clinical euvolemia, and normal thyroid and adrenal function is the SIADH pattern. Drugs are a common and reversible cause: carbamazepine, chlorpropamide, vincristine, opioids, antipsychotics, aspirin and ibuprofen are among the drugs that stimulate vasopressin secretion. Stopping or replacing the drug is part of treatment, along with fluid restriction, because the excess vasopressin keeps the kidneys retaining free water. Lithium and demeclocycline act in the opposite direction, making the collecting duct resistant to vasopressin.
A malnourished patient ventilated for 8 days repeatedly fails spontaneous breathing trials with rapid shallow breathing and weak effort. Morning labs: phosphate 0.9 mg/dL, K⁺ 3.8 mEq/L, Mg²⁺ 2.0 mg/dL. Which intervention is MOST likely to improve weaning?
Increase the sedation to improve synchrony
Increase calories as carbohydrates
IV phosphate replacement
Scheduled albuterol nebulizers
Show the answer and rationale
Answer: C
A. Deeper sedation delays weaning and does not address muscle weakness.
B. Excess carbohydrate increases CO₂ production and can worsen hypophosphatemia.
C.Correct. Severe hypophosphatemia depletes ATP and impairs diaphragm contractility, contributing to weaning failure.
D. Bronchodilators do not address weakness caused by low phosphate.
Phosphate is essential for ATP and 2,3-DPG. Severe hypophosphatemia (below 1.0 mg/dL) causes respiratory muscle weakness and failure to wean, myocardial dysfunction, rhabdomyolysis, hemolysis, and encephalopathy. It is common with refeeding, DKA treatment, alcohol use disorder, and CRRT. Severe deficits are replaced intravenously (sodium or potassium phosphate) over several hours, with calcium monitored to avoid precipitation.
Metolazone was added to high-dose IV furosemide for diuretic-resistant heart failure. Over 24 hours, net output is −5.8 L. Morning labs: K⁺ 2.9 mEq/L, Mg²⁺ 1.4 mg/dL, Na⁺ 127 mEq/L, creatinine 1.9 mg/dL (up from 1.4). The patient has frequent PVCs. Which action is the priority?
Begin amiodarone to suppress the ventricular ectopy
Replace K⁺ and Mg²⁺ and hold metolazone pending review
Start a 3% saline infusion to correct the hyponatremia
Give another metolazone dose to continue decongestion
Show the answer and rationale
Answer: B
A. The ectopy is driven by electrolyte depletion. Correcting the cause comes first.
B.Correct. Severe hypokalemia and hypomagnesemia with ectopy are the immediate danger.
C. Hypertonic saline is for severe symptomatic hyponatremia. This level needs the diuretic adjusted instead.
D. Continued aggressive diuresis with severe electrolyte depletion risks arrhythmias and worsening AKI.
Sequential nephron blockade (a loop diuretic plus a thiazide-type diuretic such as metolazone) can produce brisk diuresis, but it causes profound hypokalemia, hypomagnesemia, hyponatremia, and contraction alkalosis, as well as AKI. Frequent monitoring (often every 6–12 hours) and anticipatory replacement are essential. With significant electrolyte depletion and ectopy, the priority is to replace potassium and magnesium, hold the thiazide, and reassess the diuretic plan.
Eight hours after CABG ×2, a patient who is still intubated received furosemide 40 mg IV at 1400 for a positive fluid balance.
Data are:
1400: K 4.2 mEq/L, Mg 2.0 mg/dL, urine 70 mL/h, sinus rhythm
1800: K 3.1 mEq/L, Mg 1.5 mg/dL, urine 420 mL/h, U waves, PVC couplets
After notifying the provider, which order SHOULD the nurse anticipate?
Potassium chloride 40 mEq by tube and a level in the morning
Potassium chloride 20 mEq IV over 1 hour and magnesium sulfate 2 g IV
Potassium chloride 40 mEq IV through the central line over 10 minutes
Lidocaine 1 mg/kg IV bolus for the PVC couplets
Show the answer and rationale
Answer: B
A. Enteral potassium is slower and less predictable after surgery, and waiting until morning is too long with new ectopy.
B.Correct. Potassium at a controlled rate (20 mEq/h is a common maximum through a central line with ECG monitoring) plus magnesium replacement treats both losses from the diuresis; magnesium is needed for potassium to be retained.
C. IV potassium is right, but giving 40 mEq in 10 minutes is far above safe infusion rates and can cause cardiac arrest.
D. Lidocaine treats the ectopy but not its cause; the couplets come from low potassium and magnesium, which still need replacing.
Brisk diuresis after cardiac surgery washes out potassium and magnesium, and the post-bypass catecholamine and insulin effects shift potassium into cells. Hypokalemia flattens T waves, produces U waves and increases atrial and ventricular ectopy, including postoperative atrial fibrillation and ventricular arrhythmias. Many units keep potassium near 4.0 to 5.0 mEq/L and magnesium at 2.0 mg/dL or higher after heart surgery. IV potassium is given through a central line at a controlled rate, commonly 10 to 20 mEq/h with continuous ECG monitoring, and magnesium is replaced at the same time because low magnesium increases renal potassium loss and makes hypokalemia hard to correct. Levels are rechecked after each dose.
Tolvaptan 15 mg was given at 0800 to a patient with chronic SIADH from an inoperable brain tumor whose Na⁺ of 120 mEq/L did not improve with fluid restriction. At 1400, the patient has voided 1,600 mL, says they are very thirsty, and asks for water. The 1 L/day fluid restriction ordered on admission is still active. Which action is MOST appropriate?
Hold oral fluids until the 1400 sodium result returns
Give 500 mL of 0.9% saline to replace the urine output
Allow water to thirst and ask to end the restriction
Report the polyuria as a reason to cut the dose
Show the answer and rationale
Answer: C
A. Withholding water while the drug causes a free-water diuresis concentrates the plasma faster; thirst is the patient's built-in protection against overcorrection.
B. The diuresis is the intended effect of V2 blockade; isotonic saline adds sodium and does not answer the patient's thirst-driven need for free water.
C.Correct. The label says to avoid fluid restriction during the first 24 hours and to let patients drink in response to thirst.
D. Polyuria and thirst are expected effects of tolvaptan. Doses are adjusted from serial sodium values, not from urine volume alone.
Tolvaptan is an oral selective vasopressin V2-receptor antagonist that produces excretion of free water (aquaresis). Its prescribing information requires starting it in a hospital where sodium can be monitored closely, because a rise faster than about 12 mEq/L in 24 hours can cause osmotic demyelination; slower rates are advised with malnutrition, alcoholism, or liver disease. Fluid restriction is avoided during the first 24 hours, and patients are told they may keep drinking in response to thirst, so a fluid restriction order written before the drug should be clarified. Treatment is limited to 30 days because of liver injury, and the drug is contraindicated in patients who cannot sense or respond to thirst.
A patient receiving a continuous furosemide infusion for heart failure has a serum K⁺ of 2.6 mEq/L and frequent PVCs. Which ECG findings are MOST characteristic of this electrolyte disturbance?
Diffuse ST elevation with PR depression
A short QT interval with scooped ST segments
Flat T waves, U waves, and long QT
Peaked T waves with a widening QRS
Show the answer and rationale
Answer: C
A. This is a pericarditis pattern.
B. A short QT suggests hypercalcemia, and scooped ST segments suggest digoxin effect.
C.Correct. Hypokalemia delays repolarization, producing U waves and QT (QU) prolongation, which predisposes to torsades.
D. These are signs of hyperkalemia.
Hypokalemia causes T-wave flattening, prominent U waves, ST depression, and QU prolongation, and it increases ectopy, torsades de pointes, and digoxin toxicity. Replacement includes checking and correcting magnesium (hypomagnesemia makes hypokalemia refractory), IV potassium at safe rates (commonly up to 10 mEq/hr peripherally or 20 mEq/hr centrally with continuous ECG monitoring, per policy), and addressing ongoing losses. Target K⁺ is often 4.0 or higher in cardiac patients.
These 10 are a sample. ICU Basics has 85 electrolyte Imbalance questions, and it keeps your score, explains every choice and brings back the ones you miss. No ads. Pro is coming in January 2027.